On May 7, 2026, Wells Fargo raised the firm’s price target on MannKind Corporation (NASDAQ:MNKD) to $10 from $8 while ...

View MannKind Corporation MNKD stock quote prices, financial information, real-time forecasts, and company news from CNN.

The research firm noted that MannKind Corporation’s (NASDAQ:MNKD) first-quarter results came in below expectations, but this ...

A major catalyst window opens for this biopharma stock with Q1 earnings due on May 6, and two key FDA decisions in May and July.

Wall Street expects a year-over-year decline in earnings on higher revenues when MannKind (MNKD) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important ...

MannKind Corporation (NASDAQ:MNKD) is one of the High Growth Penny Stocks That Are Profitable in 2025. On July 23, RBC Capital’s analyst Douglas Miehm lowered the firm’s price target on MannKind ...

Investors might want to bet on MannKind (MNKD), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...

Investors in MannKind Corp (Symbol: MNKD) saw new options become available today, for the October 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD ...

MannKind Corporation (NASDAQ:MNKD) is one of the best NASDAQ stocks under $5 to buy right now. On May 6, MannKind reported total revenues of $90.2 million for Q1 2026, marking a 15% increase compared ...

For the quarter ended March 2026, MannKind (MNKD) reported revenue of $90.17 million, up 15.1% over the same period last year. EPS came in at -$0.05, compared to $0.04 in the year-ago quarter. The ...